Yunnan Baiyao responded that it lost 1.5 billion in stock speculation: it will gradually optimize the structure and gradually withdraw from securities investment
Cailian news agency, October 28 (Xinhua) -- Yunnan Baiyao lost 1.5 billion in stock speculation and boarded the hot search list. On the same day, Yunnan Baiyao told reporters: "We have received criticism and correction from all parties. In fact, we have always adhered to our main business. As for securities investment, the main purpose of joining the board at that time was to improve the use efficiency of funds. In fact, our position has been reduced to this situation. At present, the company is very cautious about the investment target, and we will gradually optimize it in the future The investment structure will also gradually withdraw from securities investment. "
This text is a result of machine translation.
Related companies：
Briefing Feb 21, 2023 11:10 AM
· Healthcare
We-Linking Raised Over CNY 10 Mn in Angel Round
Briefing Feb 21, 2023 10:07 AM
· Healthcare
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
In-depth
Healthcare
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Briefing Feb 16, 2023 12:51 PM
· Healthcare
Innovative Drug Developer Rezu Bio Raised CNY 10 Mn in Series Pre-A
Briefing Feb 15, 2023 12:32 PM
· Healthcare
ZD Medtech Raised Over CNY 100 Mn in Series B
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 18, 2022 06:30 PM
Briefing Feb 13, 2023 12:54 PM
· Healthcare
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Briefing Feb 08, 2023 11:44 AM
· Healthcare
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Briefing Feb 07, 2023 12:11 PM
· Healthcare
ForLong Biotech Nets Over CNY 100 Mn in Series A
Briefing May 18, 2022 04:45 PM
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
Healthcare
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
In-depth
Healthcare
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
Briefing Oct 30, 2021 07:57 AM
· Healthcare
Economic Daily: enterprise investment should not abandon the main business
Briefing Oct 27, 2021 04:38 PM
· Healthcare
Wanyi Technology: the net profit in the first three quarters increased by 286.04% to 5.2454 million yuan
Briefing Aug 30, 2021 08:46 AM
· Healthcare
August 30 stock market lightning rod
Briefing Jul 07, 2021 03:24 PM
· Healthcare
The first bank of China fund to release its second Quarterly Report
See more
Read next
Insight
In-depth
Healthcare · Analysis
EqualOcean｜China's Top 20 ESG Performers Among Private Enterprises（Part III）
Sep 28, 2023 10:00 AM